Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pemvidutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altimmune To Present New Data On Lipidomic Profile With Pemvidutide
    Altimmune To Present New Data On Lipidomic Profile With Pemvidutide

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963106/0/en/Altimmune-to-Present-New-Data-on-the-Lipidomic-Profile-in-Subjects-Treated-with-Pemvidutide-at-The-Liver-Meeting-2024.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    Altimmune Completes Enrollment In IMPACT Trial For Pemvidutide
    Altimmune Completes Enrollment In IMPACT Trial For Pemvidutide

    30 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/09/30/2955092/0/en/Altimmune-Completes-Enrollment-in-Phase-2b-IMPACT-Trial-of-Pemvidutide-in-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH.html

    GLOBENEWSWIRE
    30 Sep 2024
    Share Share
    Altimmune Presents Phase 2 MRI Body Composition Results
    Altimmune Presents Phase 2 MRI Body Composition Results

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943994/0/en/CORRECTION-Altimmune-Presents-Results-of-a-Phase-2-MRI-Based-Body-Composition-Sub-Study-at-60th-Annual-Meeting-of-the-European-Association-for-the-Study-of-Diabetes.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Altimmune Presents Phase 2 Body Composition Study Results
    Altimmune Presents Phase 2 Body Composition Study Results

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943567/0/en/Altimmune-Presents-Results-of-a-Phase-2-MRI-Based-Body-Composition-Sub-Study-at-60th-Annual-Meeting-of-the-European-Association-for-the-Study-of-Diabetes.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Altimmune Publishes Pemvidutide MASLD Study In Hepatology Journal
    Altimmune Publishes Pemvidutide MASLD Study In Hepatology Journal

    25 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/25/2918728/0/en/Altimmune-Announces-Publication-of-Clinical-Study-of-Pemvidutide-in-Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease-MASLD-in-Journal-of-Hepatology.html

    GLOBENEWSWIRE
    25 Jul 2024
    Share Share
    Altimmune touts 'best-in-class' lean mass results for weight loss therapy
    Altimmune touts 'best-in-class' lean mass results for weight loss therapy

    23 Jun 2024

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/altimmune-touts-best-class-lean-mass-results-weight-loss-therapy-quest-outdo-big-time

    Annalee Armstrong FIERCE BIOTECH
    23 Jun 2024
    Share Share